5Jennings MB,Weinberg JM,Koestenblatt EK,et al.Study of clinically suspected onychomycosis in a podiatric population[J].J Am Podiatr Med Assoc,2002,92:327-330.
6Gupta AK,Jain HC,Lynde CW,et al.Prevalence and epidemiology ofonychomycosis in patients visiting physicians' offices:a multicenter canadian survey of 15,000 patients[J].J Am Acad Dermatol,2000,43(2 Pt 1):244-248.
7Jessup C J, Warner J, Isham N, et al. Antifungal susceptibility tes- ting of dermatophytes : establishing a medium for inducing conidi- al growth and evaluation of susceptibility of clinical isolates[ J]. J Clin Microbio1,2000,38 ( 1 ) :341-344.
8Santos DA, Hamdan JS. Evaluation of broth microdilution antifun- gal susceptibility testing conditions for Trichophyton rubrum [ J ]. J Clin Microbiol,2005,43 (4) :1917-1920.
9Maria Elisabete da Silva Barros, Daniel de Assis Santos, Junia Soares Hamdan. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to anti- fungal drugs using a modified CLSI microdilution method ( M38- A) [J]. J Clin Microbiol, 2007, 56(4) :514-518.
10Atef S Shehata, Pranab K Mukherjee, Mahmoud A Ghannoum. Comparison between the Standardized Clinical and Laboratory Standards Institute M38-A2 Method and a 2,3-Bis(2-Methoxy-4- Nitro-5-2H-Tetrazolium Hydroxide-Based Method for Testing An- tifungal Susceptibility of Dermatophytes [ J ]. J Chn Microbiol, 2008, 46( 11 ) : 3668-3671.
